Publicaciones en las que colabora con Gorka Iriarte (11)

2014

  1. Bioanalytical chromatographic method validation according to current regulations, with a special focus on the non-well defined parameters limit of quantification, robustness and matrix effect

    Journal of Chromatography A, Vol. 1353, pp. 10-27

  2. Sindrome metabolikoa: XXI. mendearen madarikazioa

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 27, pp. 71-85

2010

  1. LC-MS/MS method for the determination of several drugs used in combined cardiovascular therapy in human plasma

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 878, Núm. 28, pp. 2685-2692

2009

  1. Optimization and validation of a SPE-HPLC-PDA-fluorescence method for the simultaneous determination of drugs used in combined cardiovascular therapy in human plasma

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 50, Núm. 4, pp. 630-639

  2. Validation of a fast liquid chromatography-UV method for the analysis of drugs used in combined cardiovascular therapy in human plasma

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 877, Núm. 27, pp. 3045-3053

2008

  1. Separation and quantitation of several angiotensin II receptor antagonist drugs in human urine by a SPE-HPLC-DAD method

    Journal of Separation Science, Vol. 31, Núm. 4, pp. 667-676

2007

  1. Biovalidation of an SPE-HPLC-UV-fluorescence method for the determination of Valsartan and its metabolite valeryl-4-hydroxy-valsartan in human plasma

    Journal of Separation Science, Vol. 30, Núm. 14, pp. 2231-2240

  2. Development of a solid phase extraction procedure for HPLC-DAD determination of several angiotensin II receptor antagonists in human urine using mixture design

    Talanta, Vol. 73, Núm. 4, pp. 748-756

2006

  1. MultiSimplex and experimental design as chemometric tools to optimize a SPE-HPLC-UV method for the determination of eprosartan in human plasma samples

    Talanta, Vol. 69, Núm. 3, pp. 747-756

  2. Optimization via experimental design of an SPE-HPLC-UV-fluorescence method for the determination of valsartan and its metabolite in human plasma samples

    Journal of Separation Science, Vol. 29, Núm. 15, pp. 2265-2283

  3. Validation of a solid phase extraction-high performance liquid chromatographic method for the determination of eprosartan in human plasma

    Journal of Chromatography A, Vol. 1119, Núm. 1-2, pp. 309-314